| Schedule of Earnings Per Share |
The
following table sets forth the computation of the Company’s basic and diluted net loss per share (unaudited) during the three and
nine months ended September 30, 2022 and 2021:
Schedule
of Earnings Per Share
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
| |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
| Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net (loss) income from continuing operations |
|
$ |
(1,339,865 |
) |
|
$ |
785,565 |
|
|
$ |
(4,105,838 |
) |
|
$ |
(4,371,860 |
) |
| Deemed dividends |
|
|
- |
|
|
|
(259,530,999 |
) |
|
|
(330,876,369 |
) |
|
|
(409,142,478 |
) |
| Net loss available to common stockholders, continuing operations |
|
|
(1,339,865 |
) |
|
|
(258,745,434 |
) |
|
|
(334,982,207 |
) |
|
|
(413,514,338 |
) |
| Net (loss) income from discontinued operations |
|
|
(1,696 |
) |
|
|
545,399 |
|
|
|
(7,075 |
) |
|
|
10,880,148 |
|
| Net loss available to common stockholders |
|
$ |
(1,341,561 |
) |
|
$ |
(258,200,035 |
) |
|
$ |
(334,989,282 |
) |
|
$ |
(402,634,190 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average number of shares of common stock outstanding during the period - basic and diluted |
|
|
10,569,572,256 |
|
|
|
43,900 |
|
|
|
4,130,876,898 |
|
|
|
15,046 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss per share of common stock available to common stockholders - basic and diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Continuing operations |
|
$ |
(0.00 |
) |
|
$ |
(5,893.97 |
) |
|
$ |
(0.08 |
) |
|
$ |
(27,483.34 |
) |
| Discontinued operations |
|
|
(0.00 |
) |
|
|
12.42 |
|
|
|
(0.00 |
) |
|
|
723.13 |
|
| Total basic and diluted |
|
$ |
(0.00 |
) |
|
$ |
(5,881.55 |
) |
|
$ |
(0.08 |
) |
|
$ |
(26,760.21 |
) |
|
| Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share |
Diluted
loss per share excludes all dilutive potential shares if their effect is anti-dilutive. As of September 30, 2022 and 2021, the following
potential common stock equivalents were excluded from the calculation of diluted loss per share as their effect was anti-dilutive:
| |
|
Nine Months September 30, |
|
| |
|
2022 |
|
|
2021 |
|
| Warrants |
|
|
511,333,351,092 |
|
|
|
18,266,394 |
|
| Convertible preferred stock |
|
|
466,707,633,333 |
|
|
|
8,977,081 |
|
| Convertible debentures |
|
|
28,777,833,333 |
|
|
|
966,494 |
|
| Stock options |
|
|
26 |
|
|
|
26 |
|
| |
|
|
1,006,818,817,784 |
|
|
|
28,209,995 |
|
|